HaloPlex Cancer Research Panel by Agilent Technologies

The HaloPlex Cancer Research Panel enables fast, simple, and efficient analysis of genomic regions of interest for cancer research for a large number of sample types, including FFPE. HaloPlex Cancer is uniquely suited to high performance with cancer research samples, which are commonly preserved as formalin fixed and paraffin embedded (FFPE). This FFPE process often results in highly fragmented DNA, resulting in insufficient sequencing target coverage.Unlike competitive technologies, HaloPlex c... Read more


HaloPlex Cancer Research Panel by Agilent Technologies product image
HaloPlex Cancer Research Panel

Agilent Technologies

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.



0 Scientists have reviewed this product


Write the First Review

No Reviews

The HaloPlex Cancer Research Panel enables fast, simple, and efficient analysis of genomic regions of interest for cancer research for a large number of sample types, including FFPE.

HaloPlex Cancer is uniquely suited to high performance with cancer research samples, which are commonly preserved as formalin fixed and paraffin embedded (FFPE). This FFPE process often results in highly fragmented DNA, resulting in insufficient sequencing target coverage.

Unlike competitive technologies, HaloPlex covers each base with several amplicons, and smaller fragments function as a backup for longer fragments that may fail. This allows for high sequencing target coverage even in highly degraded FFPE samples. FFPE also commonly produces small changes in single bases, cytosine to thymine, in DNA sequences.

HaloPlex Cancer Research Panel Features:

  • 47 genes targeting COSMIC mutations
  • Multiplex 96 samples on 1 MiSeq run
  • Compatible with Ion Torrent & Illumina Desktop Sequencers
  • Analyze samples with SureCall
  • Easily customizable in SureDesign